3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
74
Endometrial Neoplasms
10
Vaginal Neoplasms
8
Uterine Neoplasms
5
Vulvar Neoplasms
4
Neoplasms
4
Radiation Injuries
3
Ovarian Neoplasms
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Locally Advanced Cervical Cancer
2
Hyperthermia
2
Gynecologic Cancer
2
Endometrial Clear Cell Adenocarcinoma
2
Carcinoma, Ovarian Epithelial
2
Anemia
2
Uterine Cervical Dysplasia
1
To Evaluate the Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
1
Stage IA Uterine Sarcoma
1
Sarcoma
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Papillomavirus Infections
1
Locally Advanced Cervical Carcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Genital Neoplasms, Female
1
Esophageal Neoplasms
1
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
1
Endometrial Adenocarcinoma
1
Drug-Related Side Effects and Adverse Reactions
1
Desmoplastic Small Round Cell Tumor
1
Interventions
pembrolizumab
3
Paclitaxel
3
Carboplatin
3
niraparib
2
anlotinib
2
Pemetrexed
2
Palliative Care
2
Interviews as Topic
2
Gemcitabine
2
Educational Status
2
Bevacizumab
2
temsirolimus
1
relacorilant
1
olaparib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Topotecan
1
Therapeutic Touch
1
Radiotherapy
1
Pregnancy Tests
1
Ocoxin
1
Nivolumab
1
Methods
1
Human Papillomavirus DNA Tests
1
Fulvestrant
1
Filgrastim
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genital Neoplasms, Female
×
Brachytherapy
×
Gynecologic
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled